SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXC 20 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Genmab: Click to view the issuer\'s details

Last update : 25/05/2014  >View issuer details

2019.09.09 | 15:07 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab and Tempus Enter into Strategic Collaboration Agreement - HTML (w)

2019.08.30 | 07:16 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Sclerosis Studies - HTML (w)

2019.08.22 | 07:10 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan - HTML (w)

2019.08.21 | 23:59 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces Preliminary Data to be Presented at IASLC 2019 World Conference on Lung Cancer - HTML (w)

2019.08.20 | 18:47 | Permanent Information Releases / Operations

English version HTML (w) Mail

puce Capital Increase in Genmab as a Result of Employee Warrant Exercise - HTML (w)

2019.08.19 | 18:47 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Daratumumab Abstracts Selected for Presentation at 17th International Myeloma Workshop - HTML (w)

2019.08.14 | 17:00 | Permanent Information Releases / Sales and Revenues

English version HTML (w) Mail

puce Genmab Announces Financial Results for the First Half of 2019 and Updates 2019 Financial Guidance - HTML (w)

2019.07.19 | 21:52 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Major Shareholder Announcement - HTML (w)

2019.07.19 | 11:40 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering - HTML (w)

2019.07.18 | 02:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 / Doc nb : 125